Acadia Healthcare

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Acadia Healthcare posts robust Q4 results, eyes growth opportunities ahead

Acadia Healthcare's strong Q4 performance, growth strategies, and financial stability position it well for future expansion and success in the healthcare sector.
While facing challenges such as labor costs and Medicaid redeterminations, the company's focus on IT investments, strategic partnerships, and revenue diversification mitigates risks.
Opportunities in M&A, value-based programs, and revenue growth present avenues for Acadia to capitalize on market trends, enhance patient care, and drive shareholder value.

Acadia Healthcare excels in Q1 2023, navigates challenges for growth

Acadia Healthcare's strong Q1 performance, robust financial position, and strategic growth initiatives position the company for continued success and resilience.
While facing challenges such as labor inflation and benefit cost increases, Acadia's proactive approach and focus on efficiency and optimization are key to maintaining profitability.
Opportunities in expanding CTC business, achieving Medicaid rate increases, and leveraging investments in technology and marketing underscore Acadia's potential for sustained growth and operational excellence.

Acadia Healthcare excels in Q2 2023, eyes growth opportunities

Acadia Healthcare's Q2 2023 performance reflects strong financial growth and operational excellence.
The company's focus on quality care, technology, and strategic acquisitions positions it for continued success.
While facing challenges like regulatory uncertainties, Acadia Healthcare remains committed to growth and value creation.
Opportunities for expansion through acquisitions, partnerships, and operational enhancements are key focus areas for future growth.

Acadia Healthcare reports robust Q3 results and outlines growth strategies

Acadia Healthcare's Q3 performance reflects strong revenue and earnings growth, supported by operational efficiency and cost management.
While facing challenges such as start-up costs and operating expenses, the company is well-positioned to capitalize on growth opportunities.
Strategic initiatives in employee engagement, partnerships, and digitization highlight Acadia's commitment to sustainable growth and patient care.
Overall, Acadia's financial outlook remains positive, with a focus on expansion, cost optimization, and enhancing healthcare services.

Acadia Healthcare reports strong Q4 earnings and outlines growth plans

Acadia Healthcare delivered strong financial results in Q4 2023, with revenue growth, improved EBITDA, and EPS, driven by same facility revenue growth and strategic initiatives.
The company's focus on quality care, technology investments, and expansion plans position it well for continued growth and market leadership in the behavioral health care sector.
While facing challenges in labor expenses and seasonal impacts, Acadia's opportunities for growth through expansions, CTC services, and partnerships signal a positive outlook for 2024.
Overall, Acadia Healthcare's performance, strengths, and opportunities indicate a promising trajectory for sustained growth and profitability in the coming year.

Acadia Healthcare reports robust Q1 growth amidst strategic expansions

Acadia Healthcare delivered strong financial performance in Q1 2024, with revenue, EBITDA, and EPS showing significant growth. The company's strategic focus on expansion, acquisitions, and service enhancements contributed to its positive results.
While facing challenges with patient volumes and overhead costs, Acadia remains resilient and anticipates a stronger performance in the latter half of the year. Opportunities for growth through facility expansions, technology investments, and funding support position the company for continued success.
Overall, Acadia Healthcare's Q1 earnings call highlights its solid performance, strategic strengths, ongoing challenges, and promising opportunities for future growth. The company's commitment to delivering value to stakeholders and enhancing patient care underscores its position in the healthcare industry.

Acadia Healthcare posts robust Q3 results amidst legal challenges and growth opportunities

Acadia Healthcare's Q3 2024 performance reflects solid revenue growth and EBITDA expansion, underpinned by a commitment to quality care and operational efficiency.
While facing challenges from legal issues and lower volume growth, the company is actively addressing these hurdles and investing in future growth opportunities.
By navigating challenges, leveraging strengths, and capitalizing on growth opportunities, Acadia Healthcare is poised for continued success in the behavioral health care sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?

Acadia Healthcare (ACHC) Up 7.2% Since Last Earnings Report: Can It Continue?

Acadia Healthcare Company, Inc. Q3 revenue growth of 13.5% pulled in $666.7mm to the top line. Same-facility revenue stretched up by 10.2% YoY, underpinned by favorable trends in revenue per patient day and patient days.

Acadia Healthcare: Differentiated Offering Illustrates Long-Term Value

FRANKLIN, Tenn.--( BUSINESS WIRE )--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will host its first Investor Day on Wednesday, December 7, 2022, in New York City.

Acadia Healthcare to Host Investor Day

Acadia Healthcare's (ACHC) third-quarter results reflect escalating salaries, wages and benefits. The downside was partly mitigated by rising patient admissions within its U.S. facilities.

Why Acadia Healthcare (ACHC) Lost 3% Since Q3 Earnings Release

Acadia Healthcare Acquires Four CTC Facilities in Georgia

Acadia Healthcare Set to Open Four New Comprehensive Treatment Centers

Acadia Healthcare to Participate in Credit Suisse 31st Annual Healthcare Conference

Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q3 2022 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Christopher Hunter - CEO David Duckworth - CFO Gretchen Hommrich - VP, IR Conference Call Participants A.J. Rice - Credit Suisse Andrew Mok - UBS Brian Tanquilut - Jefferies Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank John Ransom - Raymond James Sarah James - Barclays Operator Good morning, and welcome to the Acadia Healthcare's Third Quarter 2022 Earnings Conference Call.

Acadia Healthcare Company, Inc. (ACHC) Q3 2022 Earnings Call Transcript

CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -2.50% and 1.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Q3 Earnings Lag Estimates

Acadia Healthcare Reports Third Quarter 2022 Results

HCA Healthcare

Tenet Healthcare

Universal Health Services

Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.

4 Stocks Navigating Through Hospital Industry Headwinds (Revised)

4 Stocks Navigating Through Hospital Industry Headwinds

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2022 results on Monday, October 31, 2022, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, November 1, 2022. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call

Acadia Healthcare Announces Date for Third Quarter 2022 Earnings Release

AbbVie

Abbott Labs

AstraZeneca

Bristol-Myers

Cardinal Health

Cigna

CVS Health

Johnson & Johnson

Merck

Novavax

Novartis

Pfizer

Regeneron Pharmaceuticals

Teladoc

UnitedHealth Group

Health care stocks are traditionally a defensive play for investors in a falling market. It's a rich market with blue chip insurance providers, service providers, pharmaceutical companies, retailers, and tech players.

Health Care Stocks: Reviewing The Best Of The Industry

Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.

Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit

PHILADELPHIA & FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and Thomas Jefferson University today announced that Acadia's Belmont Behavioral Health Hospital has entered into a formal affiliation agreement with Thomas Jefferson University's Sidney Kimmel Medical College and Jefferson Health in Philadelphia, Pennsylvania, to further teaching and clinical care opportunities for students in behavioral healthcare. This newly formed primary academic affiliation wit

Thomas Jefferson University and Acadia Healthcare Establish Primary Affiliation Agreement

FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr. Khan will oversee Acadia's network of 145 CTC facilities and associated services. He joined Acadia on September 6th following the retirement of the CTC business' previous group president. Dr. Khan will report to John Hollinsworth, EVP Operations. “The opioid epidemic is

Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business

Seelos Therapeutics

FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that select facilities from its network of acute care behavioral health hospitals will participate in a registration directed trial to study participants with suicidal ideation and behavior with major depression. This study is sponsored by Seelos Therapeutics (NASDAQ: SEEL) for its SLS-002 investigational drug. Acadia hospitals that meet the criteria for participation as clinical trial sites will be

Select Acadia Healthcare Hospitals to Participate in Clinical Trial for Acute Suicidal Ideation and Behavior in Major Depression Drug

- Acadia Healthcare is the Largest Stand-Alone Behavioral Health Company in the United States Operating a Network of Nearly 240 Behavioral Health Facilities in 39 States and Puerto Rico NEW YORK , Sept. 13, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the participation of Acadia Healthcare Company, Inc. (Nasdaq: ACHC) in the registration directed Proof of Concept study of SLS-002 (intranasal racemic ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD).

Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder

CF Industries Holdings

Few stocks hit 52-week highs amid a big market sell-off to end the week. Two stocks at new highs are industry leaders, allowing their stocks to rise with them.

Stocks At New Highs: Fertilizer Maker, Mental Health Provider Hit Buy Points

Acadia Healthcare's (ACHC) second-quarter results benefit from a strong-performing U.S. business. A raised 2022 guidance with respect to EPS bodes well.

Acadia Healthcare (ACHC) Stock Up 3% on Q2 Earnings Beat

Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Christopher Hunter - Chief Executive Officer and Director David Duckworth - Chief Financial Officer Gretchen Hommrich - Vice President, Investor Relations Conference Call Participants Andrew Mok - UBS Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Brian Tanquilut - Jefferies Benjamin Hendrix - RBC Capital Markets A.J. Rice - Credit Suisse John Ransom - Raymond James Matthew Borsch - BMO Capital Markets Sarah James - Barclays Operator Good morning, and welcome to the Acadia Healthcare Second Quarter 2022 Earnings Conference Call.

Acadia Healthcare Company, Inc. (ACHC) CEO Christopher Hunter on Q2 2022 Results - Earnings Call Transcript

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 9.09% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Tops Q2 Earnings and Revenue Estimates

FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2022. Second Quarter Highlights Revenue totaled $651.7 million, an increase of 11.9% over the second quarter of 2021 Same facility revenue increased 8.5% compared to the second quarter of 2021, including an increase in revenue per patient day of 7.8% and an increase in patient days of 0.7% Net income attributable to Acadia totaled $80.1 million

Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance

News for Acadia Healthcare Stock (ACHC)